Drug & Medication Database

11 DESCRIPTION Olmesartan medoxomil,USP a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract. Olmesartan is a selective AT1 subtype angiotensin II receptor antagonist. Olmesartan medoxomil is described chemically as 2,3-dihydroxy-2-butenyl 4-(1 hydroxy-1-methylethyl)-2-propyl-1-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]imidazole5-carboxylate, cyclic 2,3-carbonate.

Brands: Olmesartan Medoxomil

Dosage form: POWDER. Active ingredients: OLMESARTAN MEDOXOMIL (50 kg/50kg). Category: BULK INGREDIENT.

Fixed combination tablet containing olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide for the treatment of hypertension.

Brands: Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide

11 DESCRIPTION Olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets provided as a tablet for oral administration, is a fixed combination of olmesartan medoxomil (ARB), amlodipine (CCB), and hydrochlorothiazide (thiazide diuretic). Olmesartan medoxomil, a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract.

Brands: Olmesartan Medoxomil And Amlodipine Besylate And Hydrochlorothiazide

Combination tablet containing olmesartan medoxomil and hydrochlorothiazide for the treatment of hypertension.

Brands: Olmesartan Medoxomil And Hydrochlorothiazide

11 DESCRIPTION Olmesartan medoxomil, amlodipine and hydrochlorothiazide provided as a tablet for oral administration, is a fixed combination of olmesartan medoxomil (ARB), amlodipine (CCB), and hydrochlorothiazide (thiazide diuretic). Olmesartan medoxomil, a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract.

Brands: Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide

11 DESCRIPTION Olmesartan medoxomil, amlodipine and hydrochlorothiazide provided as a tablet for oral administration, is a fixed combination of olmesartan medoxomil (ARB), amlodipine (CCB), and hydrochlorothiazide (thiazide diuretic). Olmesartan medoxomil USP, a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract.

Brands: Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide

11 DESCRIPTION Olmesartan medoxomil and hydrochlorothiazide is a combination of an angiotensin II receptor antagonist (AT 1 subtype), olmesartan medoxomil, and a thiazide diuretic, hydrochlorothiazide (HCTZ). Olmesartan medoxomil is 2,3-dihydroxy-2-butenyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[ p -( o -1 H -tetrazol-5-ylphenyl)benzyl]imidazole-5-carboxylate, cyclic 2,3-carbonate.

Brands: Olmesartan Medoxomil-hydrochlorothiazide

Dosage form: POWDER. Active ingredients: OLODATEROL (15 kg/15kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: OLODATEROL HYDROCHLORIDE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: OLODATEROL HYDROCHLORIDE (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION The active moiety olodaterol is a selective beta 2 -adrenergic bronchodilator. The drug substance, olodaterol hydrochloride, is chemically described as 2H-1,4-Benzoxazin-3H(4H)-one, 6-hydroxy-8-[(1R)-1-hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]-amino]ethyl]-, monohydrochloride. Olodaterol hydrochloride is a white to off-white powder that is sparingly-slightly soluble in water and slightly soluble in ethanol.

Brands: Striverdi Respimat

Drug Facts Active Ingredients Purpose Olopatadine (0.1%) (equivalent to olopatadine hydrochloride 0.111%) Antihistamine and Redness Reliever

Brands: Olopatadine

Dosage form: POWDER. Active ingredients: OLOPATADINE HYDROCHLORIDE (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

Purpose Antihistamine and redness reliever

Brands: Olopatadine Hcl

PURPOSE Antihistamine

Brands: Eye Allergy Itch Relief

11 DESCRIPTION RYALTRIS is a metered-dose manual nasal spray unit containing an aqueous suspension of a fixed‑dose combination of a histamine-1 (H1) receptor inhibitor (olopatadine hydrochloride) and a corticosteroid (mometasone furoate monohydrate). Olopatadine hydrochloride is a white, sparingly water‑soluble crystalline powder. The chemical name for olopatadine hydrochloride is 2‑[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid hydrochloride.

Brands: Ryaltris

Active Ingredient Purpose Olopatadine (0.1%). (equivalent to olopatadine hydrochloride 0.111%) Antihistamine and redness reliever

Brands: Olopatadine Hydrochloride

Purpose Antihistamine and Redness Reliever

Brands: Rugby Olopatadine Hydrochloride Ophthalmic Solution

11 DESCRIPTION The active ingredient in DIPENTUM (olsalazine sodium) is the sodium salt of a salicylate, disodium 3,3'-azobis (6-hydroxybenzoate) a compound that is effectively bioconverted to mesalamine (5-aminosalicylic acid,5-ASA), an aminosalicylate. Its empirical formula is C14H8N2Na2O6 with a molecular weight of 346.21. The structural formula is: Olsalazine sodium is a yellow crystalline powder, which melts with decomposition at 240°C.

Brands: Dipentum

11 DESCRIPTION Olutasidenib is an isocitrate dehydrogenase-1 (IDH1) inhibitor. The chemical name is (S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile. The chemical structure is: The molecular formula is C 18 H 15 ClN 4 O 2 and the molecular weight is 354.79 g/mol. Olutasidenib is a white to off-white to brown powder that is practically insoluble in aqueous solutions between pH 1.2 and 7.4.

Brands: Rezlidhia

Manufactured by TEVA PHARMS INTL. Dosage form: POWDER. Route: SUBCUTANEOUS. Active ingredients: OMACETAXINE MEPESUCCINATE (3.5MG/VIAL). Application: NDA203585.

11 DESCRIPTION NUZYRA contains omadacycline tosylate, an aminomethylcycline which is a semisynthetic derivative of the tetracycline class of antibacterial drugs, for intravenous or oral administration. The chemical name of omadacycline tosylate is (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-9-(2,2-dimethylpropylaminomethyl)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, 4-methylbenzenesulfonate.

Brands: Nuzyra

Dosage form: POWDER. Active ingredients: OMADACYCLINE TOSYLATE (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION Omalizumab is a recombinant DNA-derived humanized IgG1κ monoclonal antibody that selectively binds to human immunoglobulin E (IgE). The antibody has a molecular weight of approximately 149 kiloDaltons. XOLAIR is produced by a Chinese hamster ovary cell suspension culture. XOLAIR (omalizumab) is administered as a subcutaneous (SC) injection and is available in prefilled syringe, autoinjector and in vials.

Brands: Xolair, Xolair Pfs, Xolair

11 DESCRIPTION Omalizumab-igec is a recombinant DNA-derived humanized IgG1κ monoclonal antibody that selectively binds to human immunoglobulin E (IgE). The antibody has a molecular weight of approximately 149 kiloDaltons. Omalizumab-igec is produced by a Chinese hamster ovary cell suspension culture. Omalizumab-igec is administered as a subcutaneous (SC) injection and is available in prefilled syringes.

Brands: Omalizumab-igec

11 DESCRIPTION SKYCLARYS contains omaveloxolone in immediate release capsules for oral administration available in a 50 mg strength. The chemical name of omaveloxolone is N-(2-cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoro-propanamide. Omaveloxolone is a white to off-white amorphous solid. The molecular formula is C 33 H 44 F 2 N 2 O 3 . Molecular weight is 554.72 g/mol.

Brands: Skyclarys

Dosage form: POWDER. Active ingredients: OMBERACETAM (1 g/g). Category: BULK INGREDIENT.

Manufactured by ABBVIE. Dosage form: TABLET, EXTENDED RELEASE. Route: ORAL. Active ingredients: DASABUVIR SODIUM (EQ 200MG BASE); OMBITASVIR (8.33MG); PARITAPREVIR (50MG); RITONAVIR (33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: NDA208624.

Manufactured by ABBVIE. Dosage form: TABLET. Route: ORAL. Active ingredients: DASABUVIR SODIUM (EQ 250MG BASE); OMBITASVIR, PARITAPREVIR, RITONAVIR (12.5MG, 75MG, 50MG). Application: NDA206619.